Wenru Song

Dr. Wenru Song is the co-founder, President and Head of R&D of Kira Pharmaceuticals, a new biotech startup based on cutting-edge immunological sciences. Dr. Song was most recently as the global VP and global clinical leader of Immuno-Oncology development at AstraZeneca Global Medicines. Previously, Dr. Song was the Head of Regional Oncology Development in Asia-Pacific at Millennium/Takeda Oncology, and global clinical lead at Pfizer Immuno-oncology. Prior to joining the pharma-industry, he was an associate investigator at Baylor Institute of Immunology Research and an attending oncologist physician at Baylor Sammons Cancer Center. He studied Medicine in Shandong University and PhD in Immunology at Texas A&M University, with internal medicine training at Montefiore Medical Center/Albert Einstein College of Medicine and medical oncology fellowship at Stanford University.